Pharmabiz20h
Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain
Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...
Pharmabiz21h
NIH-funded study finds contact lenses used to slow nearsightedness in youth have a lasting effect
NIH-funded study finds contact lenses used to slow nearsightedness in youth have a lasting effect: Bethesda, Maryland Saturday, January 18, 2025, 17:00 Hrs [IST] In a follow up st ...
Pharmabiz22h
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US
UCB’s 320 mg/2 mL prefilled syringe and autoinjector for single-injection administration option is available now in US: Brussels, Belgium Saturday, January 18, 2025, 16:00 Hrs [ ...
Pharmabiz23h
Glenmark Life Sciences rebrands as Alivus Life Sciences
Glenmark Life Sciences, a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, announces its change of ...
Pharmabiz23h
China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer
China NMPA grants marketing authorization to IMPACT Therapeutics’ Senaparib for 1L maintenance therapy in ovarian cancer: Shanghai Saturday, January 18, 2025, 15:30 Hrs [IST] IM ...
Pharmabiz23h
Caris Life Sciences collaborates with Ontada to advance oncology research and the adoption of precision medicine
Caris Life Sciences collaborates with Ontada to advance oncology research and the adoption of precision medicine: Irving, Texas Saturday, January 18, 2025, 15:00 Hrs [IST] Caris L ...